Skip to content
thispeptide

Prescriva

Prescriva identifies OpenLoop as its clinical network and lists possible dispensing pharmacies. The useful next question is who handles your actual prescription and the follow-up decisions behind it.

Review by Molly Ward, goal-guide writer · Updated October 2026

The short version

The named network and pharmacy list improve transparency, but assignment can change between orders. Confirm the professional, facility and testing requirements for your specific preparation.

Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

Lowest listed: Semaglutide injection, from $249/mo

Visit Prescriva →

Prescriva LLC operates a management platform rather than a medical practice. Independent clinicians consider prescriptions through OpenLoop Health and affiliated professional entities. Its catalog includes NAD preparations, compounded GLP-1 injections and separate low-dose protocols. Completing the preliminary assessment does not establish a clinical relationship with the platform or guarantee treatment.

What Prescriva prescribes, by goal

Weight

  • SemaglutideFDA-approved
    • Injection (compounded)From $249/mo
  • TirzepatideFDA-approved
    • Injection (compounded)From $339/mo

The product pages show general dose schedules, but the assigned clinician determines the actual prescription. Ask for instructions specific to the compounded preparation and a clear approach to missed doses or side effects. A general schedule is not an individualized treatment plan.

Longevity

  • NAD+Compounding conditions apply
    • Injection (compounded)Price not published
    • Oral (compounded)Price not published
    • Nasal spray (compounded)Price not published

The NAD page describes injection, oral and nasal routes and correctly identifies NAD as a coenzyme. Biological involvement in metabolism does not establish improved energy, cognition or lifespan from any route. Low-dose GLP-1 protocols also need their own clinical rationale rather than a broad longevity promise.

Each “From” figure is the seller’s own starting price, in the unit the seller states. Where a required fee or a package length changes what one month costs, the smaller line under it is our arithmetic, not a figure the seller prints. Compounded preparations are not FDA-approved.

Who prescribes

A licensed clinician

The terms name a clinical network, OpenLoop Health, rather than one guaranteed individual prescriber. They list RedRock Pharmacy, Health Warehouse and Precision Medicine as possible dispensing partners. The prescribing clinician selects the pharmacy according to availability, licensing and clinical considerations. Ask which practitioner and facility will be responsible for your order, including any later transfer.

An online health assessment supplies information for independent clinical review. The platform describes consultations, ongoing monitoring and patient messaging. Treatment changes are described as taking effect at a later billing cycle. Ask how earlier clinical problems are assessed and how quickly a prescriber can change an unsuitable plan. Customer-service availability does not establish continuous clinical coverage.

Are labs required?

Not mentioned

The monthly GLP-1 description includes clinician consultation, medication and shipping. It does not establish a universal included laboratory panel. Ask whether your history requires testing, who orders and interprets it and whether it costs extra. Follow-up should respond to the clinical findings rather than a routine commercial renewal alone.

Ready to start with Prescriva?

Lowest listed price: Semaglutide injection, from $249/mo. Confirm it on the seller’s own site.

What it claims, and what it cites

Prescriva distinguishes published trials of approved semaglutide from evidence for its compounded preparation. Its broader comparisons and self-reported results still do not establish superiority over other care services. RedRock has a public FDA inspection record for its Springville facility. That record is separate from the St George address listed by Prescriva. The inspection observations are not a final agency determination or evidence that a Prescriva patient was affected.

Other products and treatment claims

Unrelated cosmetic and sexual-health prescriptions
Their presence does not establish clinical evidence or inclusion within the selected GLP-1 or NAD plan.

How it bills

Standard monthly GLP-1 plans sit beside longer discounted terms and other inconsistent comparison figures. Clinical and pharmacy responsibilities remain separate even when collected in one payment. The refund policy includes exceptions for clinical disqualification and unavailable medication, while completed consultations and dispensed prescriptions generally have different limits. Confirm the agreement applicable to your actual plan.

For and against

  • For: Clinical network identified in terms
  • For: Possible dispensing pharmacies listed
  • For: Approved-product trials distinguished from compounding
  • For: Cancellation and refund exceptions published
  • Against: Actual practitioner and facility may change
  • Against: Universal testing allowance not established
  • Against: Clinical response schedule needs confirmation
  • Against: Marketing comparisons are not comparative trials

The evidence behind what it sells

Right for

Someone who wants named institutional partners and will verify the actual clinician, pharmacy and monitoring plan.

Look elsewhere if

Someone treating a general protocol or a list of possible pharmacies as a complete individual care agreement.

Other sellers for weight

Prescriva

Frequently asked questions

Does the listed pharmacy automatically fill every order?
No. The terms say the clinician selects a pharmacy and that assignment can change.
Does the cited semaglutide trial establish outcomes for the compounded product?
No. The product page distinguishes the approved preparation studied from compounded semaglutide.
Does the RedRock inspection establish that my order was affected?
No. The inspected Springville facility differs from the listed St George address, and patient impact is not established.

Sources

  • Current product catalog and clinical boundaries
  • Clinical network and named pharmacy partners
  • Standard monthly GLP-1 plans and inclusions
  • Semaglutide preparation and evidence distinction
  • Clinical decline, cancellation and refund exceptions
  • NAD routes and evidence limitations
  • RedRock Springville FDA inspection observations

See what Prescriva prescribes today

Prescriva sets its own prices, plans and the states it serves. Check them before you start.

Written by Molly Ward from Prescriva’s own public pages, against the published methodology. No outcome is claimed first-hand and no score is given. A partnership never changes what this page says; see how the site is paid.